Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: Results of a multicentre, double blind, randomised trial

J. D.C. Ross*, H. S. Cronjé, T. Paszkowski, I. Rakoczi, D. Vildaite, A. Kureishi, M. Alefelder, P. Arvis, P. Reimnitz

*Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    54 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: Results of a multicentre, double blind, randomised trial'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science